Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from...
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study
About this item
Full title
Author / Creator
on behalf of the BLESS Study Group , Lattanzi, Simona , Ranzato, Federica , Di Bonaventura, Carlo , Bonanni, Paolo , Gambardella, Antonio , Tartara, Elena , Assenza, Giovanni , Procaccini, Michela , Falsetto, Nathalie , Villano, Valentina , Camattari, Gabriele , Ori, Alessandra and Di Gennaro, Giancarlo
Publisher
Cheshire: Springer Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
Cheshire: Springer Healthcare
Subjects
More information
Scope and Contents
Contents
Introduction
Despite new anti-seizure medications (ASMs) being introduced into clinical practice, about one-third of people with epilepsy do not reach seizure control. Cenobamate is a novel tetrazole-derived carbamate compound with a dual mechanism of action. In randomized controlled trials, adjunctive cenobamate reduced the frequency of focal s...
Alternative Titles
Full title
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_639ffda6441046b8b15a3903b5051753
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_639ffda6441046b8b15a3903b5051753
Other Identifiers
ISSN
2193-8253
E-ISSN
2193-6536
DOI
10.1007/s40120-024-00634-5
